PRKAA2 and pulmonary fibrosis: In the animal model, low AMPK activity could also be found to promote pulmonary fibrosis [25–26], and the metformin as an AMPK agonist could alleviate silica-induced lung inflammation and fibrosis by regulating autophagy through AMPK activation and mTOR inhibition [26].